Ignite Creation Date:
2025-12-25 @ 3:19 AM
Ignite Modification Date:
2025-12-26 @ 1:58 AM
Study NCT ID:
NCT00323505
Status:
COMPLETED
Last Update Posted:
2006-05-09
First Post:
2006-05-08
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase II Trial Comparing the Quality of Life, Tolerability and Toxicity of PEG Intron With INTRON® A in Patients With Multiple Myeloma
Sponsor:
Royal Marsden NHS Foundation Trust
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-03
Start Date Type:
None
Primary Completion Date:
None
Primary Completion Date Type:
None
Completion Date:
2004-12
Completion Date Type:
None
First Submit Date:
2006-05-08
First Submit QC Date:
None
Study First Post Date:
2006-05-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2006-05-08
Last Update Post Date:
2006-05-09
Last Update Post Date Type:
ESTIMATED